Voloridge Investment Management, LLC Alaunos Therapeutics, Inc. Transaction History

Voloridge Investment Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$2.2 - $3.71 $174,158 - $293,694	-79,163 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$1.9 - $4.98 $150,409 - $394,231	79,163 New	79,163 $194,000
Q3 2019 Nov 14, 2019	SELL	$4.13 - $6.94 $273,220 - $459,115	-66,155 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$3.98 - $6.2 $263,296 - $410,161	66,155 New	66,155 $386,000

92.6K

Ticker TCRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,182,000
Market Cap $458M
Description
Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancrea...

Get notified when there are updates to the investment portfolio of Voloridge Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Voloridge Investment Management, LLC with notifications on news.